Equity Incentive Plan (Tables)

12 Months Ended

Dec. 31, 2019

Schedule of Additional Information on Stock Option Grants And Vesting

The following table summarizes additional information on stock option grants and vesting (in thousands):

	2016 Plan				2019 Plan
	Year Ended December 31, 2019		Year Ended December 31, 2018		Year Ended December 31, 2019		Year Ended December 31, 2018
Total fair value of stock options granted	$	2,492	$	3,473	$	974	$	-
Total fair value of options vested		1,439		1,924		-		-

Summary of Valuation Models of Fair Value of Awards Granted To Employees and Non-Employees Under 2016 Plan

The following table summarizes the assumptions used in the valuation models to determine the fair value of awards granted to employees and non- employees under both the 2019 Plan and the 2016 Plan:

	Year Ended December 31, 2019			Year Ended December 31, 2018
Expected volatility	36.92 - 37.70%			35.51 - 36.39%
Expected term (in years)	6-6.5				6.5
Dividend yield		0	%		0	%
Risk free interest rate	1.79 - 2.89%			2.59 - 2.89%

Stock Based Compensation Expense Included In Consolidated Statements of Comprehensive Loss

Stock-based compensation expense is included in the Consolidated Statements of Comprehensive Loss within the following line items (in thousands):

	December 31,
	2019		2018
Cost of revenues	$	573	$	869
General and administrative		1,161		1,023
Research and development		87		14
Sales and marketing		444		219
Total	$	2,265	$	2,125

2019 Plan [Member]

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity under the 2019 Plan:

Description	Options Outstanding		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Balance at December 31, 2018		-
Granted		514,710	$	9.90
Forfeited		-
Expired		-
Cancelled		-
Balance at December 31, 2019		514,710	$	9.90		10.0	$	—
Vested and expected to vest		514,710	$	9.90		10.0	$	—
Exercisable		—	$	—		10.0	$	—

2016 Plan [Member]

Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity under the 2016 Plan:

Description	Options Outstanding			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (1)
Balance at December 31, 2017		410,310		$	100		8.8	$	—
Granted		84,270			100
Forfeited		(74,255	)		100
Expired		(8,845	)		100
Balance at December 31, 2018		411,480		$	100		8.3	$	—
Granted		67,050		$	90
Forfeited		(32,860	)	$	99
Expired		(8,640	)	$	99
Cancelled		(437,030	)	$	100
Balance at December 31, 2019		—
Vested and expected to vest		—		$	—		—	$	—
Exercisable		—		$	—		—	$	—

(1) Aggregate intrinsic value represents the difference between the estimated fair value of the underlying common stock and the exercise price of outstanding, in-the-money options. There were no in-the-money options as of December 31, 2019 and 2018.